Tag: NASDAQ:RLYP

Finance

Morning Alert: Relypsa (NASDAQ:RLYP), American Airlines Group Inc. (NASDAQ:AAL), Isis Pharmaceuticals (NASDAQ:ISIS), Penford Corporation (NASDAQ:PENX), Nabors Industries Ltd. (NYSE:NBR)

Relypsa, Inc. (NASDAQ:RLYP) SVP Lance Berman sold 20,000 shares of the company’s stock on the open market in a transaction dated Monday, August 25th. The stock was sold at an average price of $25.89, for a total transaction of $517,800.00. Following the completion of the transaction, the senior vice president now directly owns 7,500 shares in the company, valued at approximately $194,175. Relypsa, Inc. (NASDAQ:RLYP) … Continue reading Morning Alert: Relypsa (NASDAQ:RLYP), American Airlines Group Inc. (NASDAQ:AAL), Isis Pharmaceuticals (NASDAQ:ISIS), Penford Corporation (NASDAQ:PENX), Nabors Industries Ltd. (NYSE:NBR)

Richard Atkins
Finance

Morning Alert: Tekmira Pharmaceuticals (NASDAQ:TKMR), Novavax (NASDAQ:NVAX), Relypsa (NASDAQ:RLYP), VMware, Inc. (NYSE:VMW), Cameron International (NYSE:CAM)

Equities researchers at Leerink Swann began coverage on shares of Tekmira Pharmaceuticals (NASDAQ:TKMR) in a research report issued on Monday. Tekmira Pharmaceuticals Corp. (NASDAQ:TKMR) belongs to Healthcare sector. Its weekly performance is -18.28%. On last trading day company shares ended up $19.45. Tekmira Pharmaceuticals Corp. (NASDAQ:TKMR) distance from 50-day simple moving average (SMA50) is 48.15%. Stock analysts at Citigroup Inc. assumed coverage on shares of Novavax (NASDAQ:NVAX) in … Continue reading Morning Alert: Tekmira Pharmaceuticals (NASDAQ:TKMR), Novavax (NASDAQ:NVAX), Relypsa (NASDAQ:RLYP), VMware, Inc. (NYSE:VMW), Cameron International (NYSE:CAM)

Kevin Long
Finance

Biotech Bullish Stocks: Applied Genetic Technologies (NASDAQ:AGTC), Alder Biopharmaceuticals (NASDAQ:ALDR), Concert Pharmaceuticals (NASDAQ:CNCE), Recro Pharma Inc (NASDAQ:REPH), Relypsa (NASDAQ:RLYP)

BMO Capital Markets boosted their price target on shares of Applied Genetic Technologies Corp (NASDAQ:AGTC) from $21.00 to $34.00 in a research note issued on Monday. The firm currently has an “outperform” rating on the stock. BMO Capital Markets’ target price points to a potential upside of 34.44% from the stock’s previous close. Applied Genetic Technologies Corp (NASDAQ:AGTC) stock performance was 7.57% in last session … Continue reading Biotech Bullish Stocks: Applied Genetic Technologies (NASDAQ:AGTC), Alder Biopharmaceuticals (NASDAQ:ALDR), Concert Pharmaceuticals (NASDAQ:CNCE), Recro Pharma Inc (NASDAQ:REPH), Relypsa (NASDAQ:RLYP)

Kristen Barton
business, Finance

Top Losers: Magnum Hunter Resources Corp (NYSE:MHR), eHealth (NASDAQ:EHTH), Coupons.Com (NYSE:COUP), Relypsa Inc (NASDAQ:RLYP), EDENOR (NYSE:EDN)

Magnum Hunter Resources Corp (NYSE:MHR) CEO Gary Evans recently shared with CNBC his belief that convenient location makes these shale deposits extremely promising. “There’s not a better growth story in the United States for gas than the Marcellus and Utica,” Evans said. Magnum Hunter Resources Corp (NYSE:MHR) stock performance was -5.54% in last session and finished the day at $8.35. Traded volume was 6.13million shares … Continue reading Top Losers: Magnum Hunter Resources Corp (NYSE:MHR), eHealth (NASDAQ:EHTH), Coupons.Com (NYSE:COUP), Relypsa Inc (NASDAQ:RLYP), EDENOR (NYSE:EDN)

Mark DeFrance
Finance

Biotech Decliners: Amicus Therapeutics, Inc. (NASDAQ:FOLD), Relypsa Inc (NASDAQ:RLYP), Receptos Inc (NASDAQ:RCPT), TG Therapeutics, Inc. (NASDAQ:TGTX), Chimerix Inc (NASDAQ:CMRX)

On May 9, 2014, Amicus Therapeutics, Inc. (NASDAQ:FOLD) updated its Investor Presentation for the Migalastat Monotherapy Program (the “Presentation”). The Company’s Chief Financial Officer, William D. Baird III and the Company’s Chief Operating Officer, Bradley L. Campbell, will present some or all of this Presentation to various investors in the coming months. A copy of the presentation materials is attached hereto as Exhibit 99.1. Amicus … Continue reading Biotech Decliners: Amicus Therapeutics, Inc. (NASDAQ:FOLD), Relypsa Inc (NASDAQ:RLYP), Receptos Inc (NASDAQ:RCPT), TG Therapeutics, Inc. (NASDAQ:TGTX), Chimerix Inc (NASDAQ:CMRX)

Jayne Crisman
Finance

Biotech Decliners: Insmed Incorporated (NASDAQ:INSM), 22nd Century Group Inc (NYSEMKT:XXII), Concert Pharmaceuticals Inc (NYSE:JMPC), Relypsa Inc (NASDAQ:RLYP)

Insmed Incorporated (NASDAQ:INSM) on May 13, 2014 announces that multiple posterpresentations reporting data on ARIKAYCE(TM), or liposomal amakacinfor inhalation, for the treatment of Pseudomonas aeruginosainfections in cystic fibrosis (CF) patients and for the treatment ofpatients with treatment-resistant nontuberculous mycobacterial (NTM)lung infections will be presented at the American Thoracic SocietyAnnual Meeting 2014, taking place May 16-21 in San Diego, California. Insmed Incorporated (NASDAQ:INSM) stock performance was … Continue reading Biotech Decliners: Insmed Incorporated (NASDAQ:INSM), 22nd Century Group Inc (NYSEMKT:XXII), Concert Pharmaceuticals Inc (NYSE:JMPC), Relypsa Inc (NASDAQ:RLYP)

Kevin Long